Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000521

Drug Information
NameChlorthalidone    
SynonymsOxodolin; SMR000058635; AC1Q558X; Chlorthalidone [USAN:INN:BAN]; LS-31408; Benzenesulfonamide, 2-chloro-5-(2,3-dihydro-1-hydroxy-3-oxo-1H-isoindol-1-yl)-; 3-Hydroxy-3-(4-chloro-3-sulfamylphenyl)phthalimidine; UNII-Q0MQD1073Q; AC-11367; 3-(4'-Chloro-3'-sulfamoylphenyl)-3-hydroxyphthalimidine; Prestwick_759; Oksodolin (oxodolin); AB00051946; AC1L1ECB; KBioGR_001574; Chlorothalidone; Benzenesulfonamide, 2-chloro-5-(1-hydroxy-3-oxo-1-isoindolinyl)-; MolPort-002-736-049; C14H11ClN2O4S; Clortalidone; CHEMBL1055; KBio2_005762; BSPBio_002017; NCGC00094616-03; Prestwick2_000351; Racemic chlorthalidone; Oradil; chlorthalidone; 1-Keto-3-(3'-sulfamyl-4'-chlorophenyl)-3-hydroxyisoindoline; MLS000069531; Chlortalidonum [INN-Latin]; Famolin; Urolin; NSC69200; 1-Oxo-3-(3-sulfamyl-4-chlorophenyl)-3-hydroxyisoindoline; Chlortalidone; Prestwick3_000351; HMS2091E12; Natriuran; HMS1569G03; SPBio_002362; NCGC00094616-02; G 33182; Renon; 2-chloro-5-(1-hydroxy-3-oxo-2H-isoindol-1-yl)benzenesulfonamide; Hydro-Long; 2-Chloro-5-(1-hydroxy-3-oxo-1-isoindolinyl)benzenesulfonamide; Isoren; 77-36-1; NSC 69200; CPD000058635; Clortalidone [DCIT]; ST088141; NCGC00094616-01; Spectrum5_000743; Chlorthalidone (USP); NINDS_000731; I06-0208; Hygroton (TN); D002752; Chlorthalidon; (+-)-Chlorthalidone; HMS502E13; C2775_SIGMA; CID2732; SPECTRUM1500187; BRN 0312295; Spectrum4_000957; SAM002589983; CHEBI:3654; KBio2_003194; STK686335; Prestwick0_000351; Phthalamodine; Chlortalidone (JAN/INN); Chlorphthalidolone; Prestwick1_000351; Thalitone; KBio3_001237; KBio2_000626; Spectrum_000146; BRD-A26384407-001-05-3; Chlortalidonum; 5-22-07-00602 (Beilstein Handbook Reference); C2775_FLUKA; HMS1920M09; DB00310; D00272; DivK1c_000731; BSPBio_000441; SPBio_000058; KBio1_000731; Igroton; HSDB 3035; EINECS 201-022-5; A3836/0162845; Zambesil; NCGC00094616-04; Chlorphthalidone; Saluretin; Hygroton; Spectrum2_000099; IDI1_000731; Higroton; Thalitone (TN); KBioSS_000626; Clortalidona; 2-Chloro-5-(1-hydroxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl)benzenesulfonamide; 2-chloro-5-(2,3-dihydro-1-hydroxy-3-oxo-1H-isoindol-1-yl)benzenesulfonamide; Clortalidona [INN-Spanish]; (+-)-Hygroton; Spectrum3_000349; Oxodoline; Phthalamudine; BPBio1_000487; G-33182    
IndicationHypertensionApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntihypertensive Agents    
CAS NumberCAS 77-36-1
FormularC14H11ClN2O4S    
PubChem Compound IDCID 2732.    
PubChem Substance IDSID 113212.    
ChEBI3654;    
SuperDrug ATC IDC03BA04;    
SuperDrug CAS ID000077361;    
TargetSolute carrier family 12 member 1Blocker[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 086831 To Reference
Ref 2The 45-year story of the development of an anti-aldosterone more specific than spironolactone. Mol Cell Endocrinol. 2004 Mar 31;217(1-2):45-52. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543